LDOS250117P300000
- 0.00
- 0.000.00%
Leidos Newsroom
Leidos (LDOS) Stock Slides as Market Rises: Facts to Know Before You Trade
Breaking Down Leidos Holdings: 14 Analysts Share Their Views
These Defense and Aerospace Stocks May Reap the Benefits of the Hypersonic-missile Race
Leidos Holdings Cut to Hold From Buy by TD Cowen
Leidos Holdings Is Maintained at Overweight by Wells Fargo
Leidos Holdings Analyst Ratings
Wells Fargo Maintains Leidos(LDOS.US) With Buy Rating, Cuts Target Price to $199
TD Cowen Downgrades Leidos(LDOS.US) to Hold Rating, Cuts Target Price to $165
Express News | Leidos : TD Cowen Cuts to Hold From Buy; Cuts Target Price to $165 From $200
Zacks.com Featured Highlights Include Leidos, Amazon.com, Halozyme Therapeutics and BioMarin Pharmaceutical
Melius Research Raises Leidos Holdings' Price Target to $209 From $198
Express News | Leidos Holdings Inc : UBS Cuts Target Price to $160 From $182
Express News | Veterans Benefits Administration Awards Medical Disability Examination Services Contract to Leidos Qtc Health Services
Veterans Benefits Administration Awards Medical Disability Examination Services Contract to Leidos QTC Health Services
Leidos Holdings' (NYSE:LDOS) Investors Will Be Pleased With Their Respectable 67% Return Over the Last Three Years
Leidos (LDOS) Registers a Bigger Fall Than the Market: Important Facts to Note
Do Options Traders Know Something About Leidos (LDOS) Stock We Don't?
Leidos Awarded $48.76M Army Contract
Zacks.com Featured Highlights Include The Walt Disney, Leidos, Raymond James Financial, Fortinet and The Hartford Financial Services
5 High ROE Stocks to Buy With Markets Likely to Wrap Up on a High